Back to Search
Start Over
[Combined anti-EGFR and anti-HER2 monoclonal antibodies: preclinical efficacy in the treatment of pancreatic cancer].
- Source :
-
Medecine sciences : M/S [Med Sci (Paris)] 2007 Oct; Vol. 23 (10), pp. 800-3. - Publication Year :
- 2007
- Subjects :
- Adenocarcinoma immunology
Animals
Antibodies, Monoclonal administration & dosage
Antibodies, Monoclonal immunology
Antibodies, Monoclonal, Humanized
Dimerization
ErbB Receptors chemistry
ErbB Receptors immunology
Humans
Mice
Neoplasm Proteins immunology
Pancreatic Neoplasms immunology
Panitumumab
Receptor, ErbB-2 chemistry
Receptor, ErbB-2 immunology
Trastuzumab
Xenograft Model Antitumor Assays
Adenocarcinoma therapy
Antibodies, Monoclonal therapeutic use
ErbB Receptors antagonists & inhibitors
Immunotherapy
Neoplasm Proteins antagonists & inhibitors
Pancreatic Neoplasms therapy
Receptor, ErbB-2 antagonists & inhibitors
Subjects
Details
- Language :
- French
- ISSN :
- 0767-0974
- Volume :
- 23
- Issue :
- 10
- Database :
- MEDLINE
- Journal :
- Medecine sciences : M/S
- Publication Type :
- Periodical
- Accession number :
- 17937885
- Full Text :
- https://doi.org/10.1051/medsci/20072310800